心血管老化的机制、标志物和治疗

doi:10.3969/j.issn.1003-9198.2024.03.021

摘要/Abstract

摘要： 年龄是心血管疾病(cardiovascular diseases,CVDs)的独立危险因素,心血管老化过程中常伴随功能的进行性下降。为了开发治疗CVDs的新方法,我们必须了解心血管老化发生的机制并找到衰老的特异性生物标志物。本文主要综述了心血管老化的发生机制、生物标志物及可能的治疗方法,以期为CVDs提供更多的治疗靶点。

关键词: 心血管老化, 生物标志物, 机制, 治疗, 心血管疾病

中图分类号:

R 543

陈映泉, 钟勇. 心血管老化的机制、标志物和治疗[J]. 实用老年医学, 2024, 38(3): 299-303.

[1] CAI Y, SONG W, LI J, et al. The landscape of aging[J]. Sci China Life Sci, 2022, 65(12): 2354-2454.
[2] THIJSSEN D H, CARTER S E, GREEN D J. Arterial structure and function in vascular ageing: are you as old as your arteries?[J]. J Physiol, 2016, 594(8): 2275-2284.
[3] CHEN M S, LEE R T, GARBERN J C. Senescence mechanisms and targets in the heart[J]. Cardiovasc Res, 2022, 118(5): 1173-1187.
[4] HUANG W, HICKSON L J, EIRIN A, et al. Cellular senescence: the good, the bad and the unknown[J]. Nat Rev Nephrol, 2022, 18(10): 611-627.
[5] MEHDIZADEH M, AGUILAR M, THORIN E, et al. The role of cellular senescence in cardiac disease: basic biology and clinical relevance[J]. Nat Rev Cardiol, 2022, 19(4): 250-264.
[6] VELLASAMY D M, LEE S J, GOH K W, et al. Targeting immune senescence in atherosclerosis[J]. Int J Mol Sci, 2022, 23(21):13059.
[7] ANDERSON R, LAGNADO A, MAGGIORANI D, et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence[J]. EMBO J, 2019, 38(5): e100492.
[8] ROSSIELLO F, JURK D, PASSOS J F, et al. Telomere dysfunction in ageing and age-related diseases[J]. Nat Cell Biol, 2022, 24(2): 135-147.
[9] BOOTH L K, REDGRAVE R E, TUAL-CHALOT S, et al. Heart disease and ageing: the roles of senescence, mitochondria, and telomerase in cardiovascular disease[J]. Subcell Biochem, 2023, 103: 45-78.
[10] HORVATH S, RAJ K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing[J]. Nat Rev Genet, 2018, 19(6): 371-384.
[11] EL-NACHEF D, OYAMA K, WU Y Y, et al. Repressive histone methylation regulates cardiac myocyte cell cycle exit[J]. J Mol Cell Cardiol, 2018, 121: 1-12.
[12] ALCENDOR R R, GAO S, ZHAI P, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart[J]. Circ Res, 2007, 100(10): 1512-1521.
[13] FLORIO M C, MAGENTA A, BEJI S, et al. Aging, microRNAs, and heart failure[J]. Curr Probl Cardiol, 2020, 45(12): 100406.
[14] LOZANO-VIDAL N, BINK D I, BOON R A. Long noncoding RNA in cardiac aging and disease[J]. J Mol Cell Biol, 2019, 11(10): 860-867.
[15] SONG M, FRANCO A, FLEISCHER J A, et al. Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence[J]. Cell Metab, 2017, 26(6): 872-883.
[16] MOTURI S, GHOSH-CHOUDHARY S K, FINKEL T. Cardiovascular disease and the biology of aging[J]. J Mol Cell Cardiol, 2022, 167: 109-117.
[17] GAO B, YU W, LV P, et al. Parkin overexpression alleviates cardiac aging through facilitating K63-polyubiquitination of TBK1 to facilitate mitophagy[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(1): 165997.
[18] WANG B,KOHLI J, DEMARIA M. Senescent cells in cancer therapy: friends or foes?[J]. Trends Cancer, 2020, 6(10): 838-857.
[19] CHATTERJEE S, HOFER T, COSTA A, et al. Telomerase therapy attenuates cardiotoxic effects of doxorubicin[J]. Mol Ther, 2021, 29(4): 1395-1410.
[20] CAMELL C D, YOUSEFZADEH M J, ZHU Y, et al. Senolytics reduce coronavirus-related mortality in old mice[J]. Science, 2021, 373(6552): eabe4832.
[21] KHAVINSON V, LINKOVA N, DYATLOVA A, et al. Senescence-associated secretory phenotype of cardiovascular system cells and inflammaging: perspectives of peptide regulation[J]. Cells, 2022, 12(1): 106.
[22] REHKOPF D H, NEEDHAM B L, LIN J, et al. Leukocyte telomere length in relation to 17 biomarkers of cardiovascular disease risk: a cross-sectional study of US adults[J]. PLoS Med, 2016, 13(11): e1002188.
[23] LUCAS V, CAVADAS C, AVELEIRA C A. Cellular senescence: from mechanisms to current biomarkers and senotherapies[J]. Pharmacol Rev, 2023, 75(4):675-713.
[24] EVANGELOU K, VASILEIOU P, PAPASPYROPOULOS A, et al. Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem[J]. Physiol Rev, 2023, 103(1): 609-647.
[25] CHANG J, WANG Y, SHAO L, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice[J]. Nat Med, 2016, 22(1): 78-83.
[26] MARTIN N, SORIANI O, BERNARD D. Cardiac glycosides as senolytic compounds[J]. Trends Mol Med, 2020, 26(3): 243-245.
[27] FUHRMANN-STROISSNIGG H, LING Y Y, ZHAO J, et al. Identification of HSP90 inhibitors as a novel class of senolytics[J]. Nat Commun, 2017, 8(1): 422.
[28] HAN Y M, BEDARIDA T, DING Y, et al. Beta-Hydroxybutyrate prevents vascular senescence through hnRNP A1-mediated upregulation of Oct4[J]. Mol Cell, 2018, 71(6): 1064-1078.
[29] CAI Y, ZHOU H, ZHU Y, et al. Elimination of senescent cells by beta-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice[J]. Cell Res, 2020, 30(7): 574-589.
[30] AMOR C, FEUCHT J, LEIBOLD J, et al. Senolytic CAR T cells reverse senescence-associated pathologies[J]. Nature, 2020, 583(7814): 127-132.
[31] MENDELSOHN A R, LARRICK J W. Antiaging vaccines targeting senescent cells[J]. Rejuvenation Res, 2022, 25(1): 39-45.
[32] CHAIB S, TCHKONIA T,KIRKLAND J L. Cellular senescence and senolytics: the path to the clinic[J]. Nat Med, 2022, 28(8): 1556-1568.
[33] TAI S, SUN J, ZHOU Y, et al. Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux[J]. J Adv Res, 2022, 41: 205-218.
[34] CHI B, ZOU A, MAO L, et al. Empagliflozin-pretreated mesenchymal stem cell-derived small extracellular vesicles attenuated heart injury[J]. Oxid Med Cell Longev, 2023, 2023: 7747727.

心血管老化的机制、标志物和治疗

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	汪月, 李振光, 李梦凡, 张金彪, 齐笑笑. 肌少症与老年人认知功能障碍相关发病机制的研究进展[J]. 实用老年医学, 2024, 38(8): 857-861.
[2]	杨绍孔, 陈立文, 沈华, 张铮. 脓毒症心肌病诊断及预后标志物的研究进展[J]. 实用老年医学, 2024, 38(7): 748-752.
[3]	赵倩文, 孙斌, 朱杨子, 顾小萍, 王立伟. 老年病人术后认知功能障碍诊断与干预策略的研究进展[J]. 实用老年医学, 2024, 38(5): 447-437.
[4]	唐娜, 郭华, 张云云, 崔小川. 谷氧还蛋白1在氧化应激引起的老年多发疾病中的研究进展[J]. 实用老年医学, 2024, 38(5): 516-437.
[5]	董昱, 葛伟. 中药菟丝子抗衰老作用研究进展[J]. 实用老年医学, 2024, 38(3): 219-222.
[6]	李毛毛, 李洁华. 枸杞多糖抗衰老的研究进展[J]. 实用老年医学, 2024, 38(3): 223-227.
[7]	朱晨晨, 秦海东. 斑块侵蚀在急慢性冠脉综合征发生发展中的作用[J]. 实用老年医学, 2024, 38(3): 308-311.
[8]	朱武刚, 翟晨彤, 刘德干, 徐文静. 外周血中性粒细胞与淋巴细胞比值对老年转移性食管癌免疫治疗预后的影响[J]. 实用老年医学, 2024, 38(2): 171-175.
[9]	杨娜, 韩炜. 老年便秘与心身疾病[J]. 实用老年医学, 2024, 38(10): 974-978.
[10]	张书虎, 李甜甜. 自噬在心血管健康和疾病中的研究进展[J]. 实用老年医学, 2024, 38(1): 77-80.
[11]	于世林, 袁梅英, 耿亚辉, 马娜敏, 王敏, 聂圆圆, 董建全, 张亚清. 有氧运动治疗老年2型糖尿病周围神经病变疗效观察[J]. 实用老年医学, 2016, 30(6): 465-.
[12]	汪庚明, 周育夫, 张雷, 张亚军, 孙谦, 江浩, 徐洪波. 奈达铂与替加氟同步化疗联合放疗治疗老年食管癌的疗效观察[J]. 实用老年医学, 2016, 30(1): 20-.
[13]	林秀珠. 老年脑卒中患者的连续规范化康复治疗方法及效果观察[J]. 实用老年医学, 2016, 30(09): 736-738.
[14]	夏丽华, 李耀扬. 持续性低效率每日血液透析滤过对糖尿病肾病合并急性肾损伤患者的疗效[J]. 实用老年医学, 2015, 29(8): 659-.
[15]	段立晖, 陈响亮, 熊云云, 刘新峰. 颈动脉支架置入对颈动脉狭窄患者认知功能影响的随访观察[J]. 实用老年医学, 2015, 29(5): 375-.